Journal of Molecular and Cellular Cardiology
Volume 43, Issue 2 , Pages 187-196 , August 2007

T75M-KCNJ2 mutation causing Andersen–Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity

  • Yoshinori Tani

      Affiliations

    • Department of Bio-Informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan
    • Department of Cardiovascular Medicine, Okayama Univeristy Graduate, School of Medicine, Dentistry and Pharmaceutical, Sciences, Okayama, Japan
    • ,
  • Daiji Miura

      Affiliations

    • Department of Cardiovascular Medicine, Okayama Univeristy Graduate, School of Medicine, Dentistry and Pharmaceutical, Sciences, Okayama, Japan
    • ,
  • Junko Kurokawa

      Affiliations

    • Department of Bio-Informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan
    • ,
  • Kazufumi Nakamura

      Affiliations

    • Department of Cardiovascular Medicine, Okayama Univeristy Graduate, School of Medicine, Dentistry and Pharmaceutical, Sciences, Okayama, Japan
    • ,
  • Mamoru Ouchida

      Affiliations

    • Department of Molecular Genetics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical, Sciences, Okayama, Japan
    • ,
  • Kenji Shimizu

      Affiliations

    • Department of Molecular Genetics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical, Sciences, Okayama, Japan
    • ,
  • Tohru Ohe

      Affiliations

    • Department of Cardiovascular Medicine, Okayama Univeristy Graduate, School of Medicine, Dentistry and Pharmaceutical, Sciences, Okayama, Japan
    • ,
  • Tetsushi Furukawa

      Affiliations

    • Department of Bio-Informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 5280 8070; fax: +81 3 5280 8071.

Received 30 November 2006 ,Revised 4 April 2007 ,Accepted 4 May 2007.

References 

  1. Andersen ED, Krasilnikoff PA, Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?. Acta Paediatr. Scand. 1971;60:559–564
  2. Tawil R, Ptacek LJ, Pavlakis SG, DeVivo DC, Penn AS, Ozdemir C, et al. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann. Neurol. 1994;35:326–330
  3. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell. 2001;105:511–519
  4. Ai T, Fujiwara Y, Tsuji K, Otani H, Nakano S, Kubo Y, et al. Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia. Circulation. 2002;105:2592–2594
  5. Hosaka Y, Hanawa H, Washizuka T, Chinushi M, Yamashita F, Yoshida T, et al. Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome. J. Mol. Cell. Cardiol. 2003;35:409–415
  6. Donaldson MR, Jensen JL, Tristani-Firouzi M, Tawil R, Bendahhou S, Suarez WA, et al. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology. 2003;60:1811–1816
  7. Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL, Benson DW. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am. J. Hum. Genet. 2002;71:663–668
  8. Bendahhou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, Fu YH, Ptacek LJ. Defective potassium channel Kir2.1 trafficking underlies Andersen–Tawil syndrome. J. Biol. Chem. 2003;278:51779–51785
  9. Fodstad H, Swan H, Auberson M, Gautschi I, Loffing J, Schild L, et al. Loss-of-function mutations of the K+ channel gene KCNJ2 constitute a rare cause of long QT syndrome. J. Mol. Cell. Cardiol. 2004;37:593–602
  10. Ballester LY, Benson DW, Wong B, Law IH, Mathews KD, Vanoye CG, et al. Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome. Human Mutat. 2006;27:388
  11. Lange PS, Er F, Gassanov N, Hoppe UC. Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion. Cardiovasc. Res. 2003;59:321–327
  12. Kubo Y, Baldwin TJ, Jan YN, Jan LY. Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature. 1993;362:127–133
  13. Stanfield PR, Nakajima S, Nakajima Y. Constitutively active and G-protein coupled inward rectifier K+ channels: Kir2.0 and Kir3.0. Rev. Physiol. Biochem. Pharmacol. 2002;145:47–179
  14. Nakamura TY, Artman M, Rudy B, Coetzee WA. Inhibition of rat ventricular IK1 with antisense oligonucleotides targeted to Kir2.1 mRNA. Am. J. Physiol. 1998;274:892–900
  15. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108:193–199
  16. Kurokawa J, Chen L, Kass RS. Requirement of subunit expression for cAMP-mediated regulation of a heart potassium channel. Proc. Natl. Acad. Sci. U. S. A. 2003;100:2122–2127
  17. Bai CX, Namekata I, Kurokawa J, Tanaka H, Shigenobu K, Furukawa T. Role of nitric oxide in Ca2+ sensitivity of the slowly activating delayed rectifier K+ current in cardiac myocytes. Circ. Res. 2005;96:64–72
  18. Fujiwara Y, Kubo Y. Ser165 in the second transmembrane region of the Kir2.1 channel determines its susceptibility to blockade by intracellular Mg2+. J. Gen. Physiol. 2002;102:677–693
  19. Matsuda H, Saigusa A, Irisawa H. Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+. Nature. 1987;325:156–159
  20. Ishihara K, Yan DH, Yamamoto S, Ehara T. Inward rectifier K+ current under physiological cytoplasmic conditions in guinea-pig cardiac ventricular cells. J. Physiol. 2002;540:831–841
  21. Eckhardt LL, Farley AL, Rodriguez E, Ruwaldt K, Hammill D, Tester DJ, et al. KCNJ2 mutations in arrhythmia patients referred for LQT testing: A mutation T305A with novel effect on rectification properties. Heart Rhythm. 2007;4:323–329
  22. Davies NP, Imbrici P, Fialho D, Herd C, Bilsland LG, Weber A, et al. Andersen–Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology. 2005;65:1083–1089
  23. Lopatin AN, Makhina EN, Nichols CG. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature. 1994;372:366–369
  24. Tamarappoo BK, Verkman AS. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J. Clin. Invest. 1998;101:2257–2267
  25. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. KVLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature. 1996;384:78–80
  26. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, et al. Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature. 1996;384:80–83
  27. Martin RL, Koumi S, TenEick RE. Comparison of the effects of internal [Mg2+] on IK1 in cat and guinea-pig cardiac ventricular myocytes. J. Mol. Cell. Cardiol. 1995;27:673–691
  28. Ishihara K, Ehara T. Two modes of polyamine block regulating the cardiac inward rectifier K+ current IK1 as revealed by a study of the Kir2.1 channel expressed in a human cell line. J. Physiol. 2004;556:61–78
  29. Nishida M, MacKinnon R. Structural basis of inward rectification: cytoplasmic pore of the G protein-gated inward rectifier GIRK1 at 1.8 Å resolution. Cell. 2002;111:957–965
  30. Pegan S, Arrabit C, Zhou W, Kwiatkowski W, Collins A, Slesinger PA, et al. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nat. Neurosci. 2005;8:279–287
  31. Zhang L, Benson DW, Tristani-Firouzi M, Ptacek LJ, Tawil R, Schwartz PJ, et al. Electrocardiographic features in Andersen–Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation. 2005;111:2720–2726
  32. McLerie M, Lopatin A. Dominant-negative suppression of IK1 in the mouse heart leads to altered cardiac excitability. J. Mol. Cell. Cardiol. 2003;35:367–378
  33. Lu C-W, Lin J-H, Rajawat YS, Jerng H, Rami TG, Sanchez X. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen–Tawil syndrome. J. Med. Genet. 2006;43:653–659
  34. Wellner-Kienitz M-C, Bender K, Rinne A, Pott L. Voltage dependence of ATP-dependent K+ current in rat cardiac myocytes is affected by IK1 and IK(Ach). J. Physiol. 2004;561.2:459–469
  35. Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, et al. A Novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ. Res. 2005;96:800–807
  36. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J. Clin. Invest. 2002;110:381–388

PII: S0022-2828(07)01024-3

doi: 10.1016/j.yjmcc.2007.05.005

Journal of Molecular and Cellular Cardiology
Volume 43, Issue 2 , Pages 187-196 , August 2007

Article Tools

* Image Usage & Resolution